Nutritional Factors that Can Favorably Influence the Glucose/Insulin System: Vanadium

Journal of the American College of Nutrition

Volumn 17, Issue 1, 1998, Pages 11-18

  Verma, Subodh ^a   Cam, Margaret C ^a   McNeill, John H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Diabetes; Insulin resistance; Vanadium

Indexed keywords

VANADIUM;

DIET SUPPLEMENTATION; DRUG POTENCY; DRUG SYNTHESIS; HEART PROTECTION; HUMAN; INSULIN LIKE ACTIVITY; NUTRITIONAL VALUE; REVIEW;

ANIMALS; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; NUTRITION PHYSIOLOGY; VANADIUM;

EID: 0031891525     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.1998.10718730     Document Type: Article

References (65)

1. Heyliger CE, Tahiliani AG, McNeill JH: Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227:1474-1477, 1985.
2. Byrne AR, Kosta L: Vanadium in foods and in human body fluids and tissues. Sci Total Environ 10:17-30, 1993.
3. Nechay BR: Mechanisms of action of vanadium. Ann Rev Pharmacol Toxicol 24:501-524, 1984.
4. Talvite NA, Wagner WD: Studies in vanadium toxicology. Arch Ind Hyg Occup Med 9:414-422, 1954.
5. Nakai M, Watanabe H, Fujiwara C, Kakegawa H, Satoh T, Takeda J, Matsushita R, Sakurai H: Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds. J Pharm Soc Jap 18:119-125, 1995.
6. Duckworth WC, Solomon SS, Liepnieks J, Hamel FG, Hand S, Peavy DE: Insulin-like effects of vanadate in isolated rat adipocytes. Endocrinology 122:2285-2289, 1988.
7. Shechter Y, Karlish SJD: Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions. Nature 284:556-558, 1980.
8. Tamura S, Brown TA, Whipple JH, Fujita-Yamaguchi Y, Dubler RE, Cheng K, Larner J: A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. J Biol Chem 259:6650-6658, 1984.
9. Tamura S, Brown TA, Dubler RE, Larner J: Insulin-like effect of vanadate on adipocyte glycogen synthase and on phosphorylation of 95, 000 dalton subunit of insulin receptor. Biochem Biophys Res Comm 113:80-86, 1983.
10. McNeill JH, Yuen VG, Dai S, Orvig C: Increased potency of vanadium using organic ligands. Mol Cell Biochem 153:175-180, 1995.
11. Orvig C, Thompson KH, Battell M, McNeill JH: Vanadium compounds as insulin mimics. In Sigel H, Sigel A (eds) “Metal Ions in Biological Systems” New York: Marcel Dekker, Inc, 1995.
12. Jackson T, Salhanick AI, Sparks JD, Sparks CE, Bolognino M, Amatrude JM: Insulin-mimetic effects of vanadate in primary cultures of rat hepatocytes. Diabetes 37:1234-1240, 1954.
13. Morita T, Imagawa T, Kanagawa A, Ueki H: Sodium orthovanadate increases phospholipase A2 activity in isolated rat fat pats: a role of phospholipase A2 in the vanadate stimulated release of lipoprotein lipase activity. Biol Pharm Bull 18:347-349, 1995.
14. Maher PA: Stimulation of endothelial cell proliferation by vanadate is specific for microvascular endothelial cells. J Cell Physiol 151:549-554, 1992.
15. Barnes DM, Sykes DB, Shechter Y, Miller DS: Multiple sites of vanadate and peroxovanadate action in Xenopus oocytes. J Cell Physiol 162:154-161, 1995.
16. Hajjar JJ, Fucci JC, Rowe WA, Tomicic TK: Effect of vanadate on amino acid transport in rat jejunum. Proc Natl Acad Sci USA 184:403-409, 1987.
17. Bhanot S, Bryer-Ash M, Cheung A, McNeill JH: Bis(maltolato) oxovanadium(IV) attenuates hyperinsulinemia and hypertension in spontaneously hypertensive rats. Diabetes 43:857-861, 1994.
18. Meyerovitch J, Farfel Z, Sack J, Shechter Y: Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. J Biol Chem 262:6658-6662, 1987.
19. Brichard SM, Okitolonda W, Henquin JC: Long-term improvement of glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology 123:2048-2053, 1988.
20. Ramanadham S, Cros GH, Mongold JJ, Serrano JJ, McNeill JH: Enhanced in vivo sensitivity of vanadyl treated diabetic rats to insulin. Can J Physiol Pharmacol 68:486-491, 1990.
21. Blondel O, Bailbe D, Portha B: In vivo insulin resistance in streptozotocin-diabetic rats-evidence for reversal following vanadate treatment. Diabetologia 32:185-190, 1989.
22. Miralpeix M, Carballo E, Bartrons R: Effects of vanadate on 6-phosphofructo 2-kinase activity and fructose 2, 6 bisphosphate levels in cultured rat hepatocytes. Cell Biochem Func 8:237-241, 1990.
23. Hei Y-J, Chen X, Pelech SL, Diamond J, McNeill JH: Skeletal muscle mitogen activated protein kinases and ribosomal S6 kinases. Suppression in chronic diabetes and reversal by vanadium. Diabetes 44:1147-1155, 1995.
24. Gil J, Miralpeix M, Carreras J, Bartrons R: Insulin like effects of vanadate on glucokinase activity and fructose 2, 6 bisphosphate levels in livers of diabetic rats. J Biol Chem 263:1868-1871, 1988.
25. Pugazhenthi S, Khandelwal R: Insulin-like effects of vanadate on hepatic glycogen metabolism in nondiabetic and streptozotocininduced diabetic rats. Diabetes 39:821-827, 1990.
26. Brichard SM, Desbuquois B, Girard J: Vanadate treatment of diabetic rats reverses the impaired expression of genes involved in hepatic glucose metabolism: effects on glycolytic and gluconeogenic enzymes and on glucose transporter GLIT2. Mol Cell Endocrinol 91:91-97, 1993.
27. Thompson KH, McNeill JH: Effect of vanadyl sulfate feeding on susceptibility to peroxidative change in diabetic rats. Res Comm Chem Path Pharmacol 80:187-200, 1993.
28. Hudson TGF: “Vanadium, Toxicology and Biological Significance.” New York: Elsevier, 1964.
29. Tolman ED, Barris E, Burns M, Pansini A, Partridge R: Effects of vanadium on glucose metabolism in vitro. Life Sci 25:1159-1164, 1979.
30. Ramanadham S, Brownsey RW, Cros GH, Mongold JJ, McNeill JH: Sustained prevention of myocardial abnormalities in diabetic rats following withdrawal from oral vanadyl treatment. Metabolism 38:1022-1028, 1989.
31. Cam MC, Faun J, McNeill JH: Concentration-dependent glucose lowering effects of vanadyl are maintained following treatment withdrawal in streptozotocin diabetic rats. Metabolism 44:332-339, 1995.
32. Ramanadham S, Mongold JJ, Brownsey RW, Cros GH, McNeill JH: Oral vanadyl sulfate in treatment of diabetes mellitus in rats. Am J Physiol 257:H904-H911, 1989.
33. Rossetti L, Laughlin MR: Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle. J Clin Invest 84:892-899, 1989.
34. Blondel O, Simon J, Chevalier B, Portha B: Impaired insulin action but normal insulin receptor activity in diabetic rat liver: effect of vanadate. Am J Physiol 258:E459-467, 1990.
35. Brichard SM, Pottier AM, Henzuin JC: Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fajfa rats. Endocrinology 125:2510-2516, 1989.
36. Brichard SM, Bailey CJ, Henzuin JC: Marked improvement of glucose homeostasis in diabetic objob mice given oral vanadate. Diabetes 39:1326-1332, 1990.
37. McNeill JH, Yuen VG, Hoveyda HR, Orvig C: Bis(maltolato)oxovanadium(IV) is a potent insulin mimic. J Med Chem 35:1489-1491, 1992.
38. Yuen VG, Orvig C, McNeill JH: Comparison of the glucoselowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration. Can J Physiol Pharmacol 73:55-64, 1995.
39. Dai S, Vera E, McNeill JH: Lack of haematological effect of oral vanadium treatment in rats. Pharmacol Toxicol 76:263-268, 1995.
40. Yuen VG, Orvig C, McNeill JH: Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV). Can J Physiol Pharmacol 71:263-269, 1993.
41. Yuen VG, Pederson RA, Dai S, Orvig C, McNeill JH: The effects of low and high dose administration of bis(maltolato)oxovanadium(IV) on fajfa Zucker rats. Can J Physiol Pharmacol (in press).
42. Bhanot S, McNeill JH: Insulin and hypertension: a causal relationship? Cardiovasc Res 31:212-221, 1996.
43. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diab Care 14: 173-194, 1991.
44. Ferrannini E, Natali A: Essential hypertension, metabolic disorders and insulin resistance. Am Heart J 121:1274-1282, 1991.
45. Bhanot S, Michoulas A, McNeill JH: Antihypertensive effects of vanadium compounds in hyperinsulinemic, hypertensive rats. Mol Cell Biochem 153:205-209, 1995.
46. Bhanot S, McNeill JH: Vanadyl sulfate lowers plasma insulin levels and blood pressure in spontaneously hypertensive rats. Hypertension 24:625-632, 1994.
47. Bhanot S, McNeill JH, Bryer-Ash M: Vanadyl sulfate prevents fructose induced hyperinsulinemia and hypertension in rats. Hypertension 23:308-312, 1994.
48. Swarup G, Cohen S, Garbers DI: Inhibition of membrane phosphotyrosyl-protein phosphotase activity by vanadate. Biochem Biophys Res Commun 107:1104-1109, 1982.
49. Tracey AS, Gresser MJ: Interaction of vanadate with phenol and tyrosine: implications for the effects of vanadate on systems regulated by tyrosine phosphorylation. Proc Natl Acad Sci USA 83:609-613, 1986.
50. Ueno A, Arakaki N, Takeda Y, Fujio H: Inhibition of tyrosine autophosphorylation of the solubilized insulin receptor by an insulin-stimulating peptide derived from bovine serum albumin. Biochem Biophys Res Commun 144:11-18, 1987.
51. Gherzi R, Caratti G, Andraghetti G, Bertolini S, Montemurro A, Sesto G, Cordera R: Direct modulation of insulin receptor protein tyrosine kinase by vanadate and anti-insulin receptor monoclonal antibodies. Biochem Biophys Res Commun 152:1474-1480, 1988.
52. Smith DM, Sale GJ: Evidence that a novel serine kinase catalyses phosphorylation of the insulin receptor in an insulin-dependent and tyrosine kinase-dependent manner. Biochem J 256:903-909, 1988.
53. Green A: The insulin like effect of sodium vanadate on adipocyte transport is mediated at a post-insulin receptor level. Biochem J 238:663-669, 1993.
54. Mooney RA, Bordwell KL, Luhowskyj S, Casnelle JE: The insulin-like effect of vanadate on lipolysis in rat adipocytes is not accompanied by insulin-like effect on tyrosine phosphorylation. Endocrinology 124:422-429, 1989.
55. Shisheva A, Shechter Y: Role of cytosolic tyrosine kinase in mediating the insulin-like actions of vanadate in rat adipocytes. J Biol Chem 268:6463-6469, 1993.
56. Shechter Y, Shisheva A, Lazar R, Libman J, Shanzer A: Hydrophobic carriers of vanadyl ions augement the insulinomimetic actions of vanadyl ions in rat adipocytes. Biochemistry 31:2063- 2068, 1992.
57. Sekar N, Li J, Shechter Y: Vanadium salts as insulin substitutes: mechanism of action, a scientific and therapeutic tool in diabetes mellitus research. Crit Rev Biochem Mol Biol 31:339-359, 1996.
58. Hei Y-J, Diamond J, McNeill JH: Distribution of MAP kinase, S6 kinase and casein kinase-2 in rat tissues: activation by insulin in spleen. Biochem Cell Biol 72:49-53, 1994.
59. Cam MC, Li WM, McNeill JH: Partial preservation of pancreatic b-cells by vanadium: evidence for chronic amelioration of diabetes. Metabolism (in press).
60. Goldfine AB, Simonson DC, Folli F, Patti ME, Kahn CR: Metabolic effects of sodium metavanadate in humans with insulindependent and non-insulin-dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab 80:3311-3320, 1995.
61. Cohen N, Halberstam M, Shlimovich P, Chang CJ, Shamoon H, Rossetti L: Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin dependent diabetes mellitus. J Clin Invest 95:2501-2509, 1995.
62. Malabu US, Dryden S, McCarthy HD, Kilpatrick A, Williams G: Effects of chronic vanadate administration in the STZ-diabetic rat. The antihyperglycemic action of vanadate is attributable entirely to its suppression of feeding. Diabetes 43:9-15, 1994.
63. Yuen VG, Orvig C, McNeill JH: Effects of bis(maltolato)oxovanadium(IV) are distinct from food restriction in STZ-diabetic rats. Am J Physiol 272:E30-E35, 1997.
64. Cam MC: Studies on the mechanism if the insulin mimetic effects of vanadium in streptozotocin-diabetic rats. (PhD Thesis). The University of British Columbia, Vancouver, Canada, 1996.
65. Nielson FH: Vanadium in mammalian physiology and nutrition. In “Metal Ions in Biological Systems” 31:543-573, 1995. “Vanadium and Its Role in Life”, H. Sigel and A. Sigel (Ed), New York: Marcel Dekker, Inc, 1995.